Write a reviewFor vendors
♡
Home / Investors / Karl Rothweiler

Karl Rothweiler

Venture Fund · De Bilt

About Karl Rothweiler

Venture capital investor (Founding Investor, Member of the Supervisory Board) based in De Bilt, The Netherlands. Focus areas include Health Care, Research and Development, Drug Discovery. Invests at seed stage. Past investments include ORCA Therapeutics, Capgemini, Cristal Therapeutics.

Investment focus

Stages
Seed
Sectors
Health CareResearch and DevelopmentDrug DiscoveryWellnessImmunotherapyLife ScienceEngineeringPortfolio ManagementInformation Technology (IT)3D TechnologyBiotechnologyMarket ResearchInnovationClinical TrialsFinTechResearchSocial ImpactRegulatory ComplianceMedicalB2B

Portfolio

No portfolio companies recorded yet; Karl Rothweiler reports 14 investments overall.

Similar investors

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Abbie Celniker

Venture Fund · Newton
SeedHealth CareDrug DiscoveryAutoimmune DiseasesWellness+16
60Investments
—Exits

Abhinaya Konduru

Venture Fund · Chicago
SeedPre-SeedEarly Stage VentureHealth CareE-commercePaymentsCybersecurity+16
60Investments
—Exits

Adam Cragg

Angel Investor · Calgary
SeedPre-SeedEarly Stage VentureSeries AAdvertisingHealth CareCybersecurityEnterprise Software+16
60Investments
—Exits

Adam Rothenberg

Angel Investor · New York City
SeedPre-SeedEarly Stage VentureSeries AHealth CareE-commerceMessagingDisruptive Innovation+16
60Investments
—Exits